Purdue Pharma L.P. Sustainability Profile
Purdue Pharma L.P., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1892, the company has established itself as a leader in pain management and addiction treatment, with a focus on developing innovative therapies. Purdue Pharma is best known for its flagship product, OxyContin, which revolutionised pain relief but also sparked significant discussions around opioid use and addiction. With a commitment to addressing public health challenges, Purdue Pharma has expanded its portfolio to include a range of medications aimed at treating various conditions, including opioid use disorder. The company has made notable strides in research and development, positioning itself as a key contributor to the ongoing dialogue about responsible pain management. Through its dedication to improving patient outcomes, Purdue Pharma continues to navigate the complexities of the pharmaceutical landscape.
DitchCarbon Score
How does Purdue Pharma L.P.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Purdue Pharma L.P.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Purdue Pharma L.P.'s reported carbon emissions
Purdue Pharma L.P., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. Given the lack of emissions data and reduction initiatives, it is unclear how Purdue Pharma L.P. is addressing its carbon footprint or contributing to climate action. The absence of commitments may reflect a broader context within the pharmaceutical industry, where companies are increasingly being called upon to enhance transparency and accountability regarding their environmental impact.
How Carbon Intensive is Purdue Pharma L.P.'s Industry?
How Carbon Intensive is Purdue Pharma L.P.'s Location?
Purdue Pharma L.P.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Purdue Pharma L.P. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
